Details for New Drug Application (NDA): 018709
✉ Email this page to a colleague
NDA 018709 describes CAPOZIDE 50/25, which is a drug marketed by Apothecon and is included in one NDA. Additional details are available on the CAPOZIDE 50/25 profile page.
The generic ingredient in CAPOZIDE 50/25 is captopril; hydrochlorothiazide. There are fifteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the captopril; hydrochlorothiazide profile page.
The generic ingredient in CAPOZIDE 50/25 is captopril; hydrochlorothiazide. There are fifteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the captopril; hydrochlorothiazide profile page.
Summary for 018709
| Tradename: | CAPOZIDE 50/25 |
| Applicant: | Apothecon |
| Ingredient: | captopril; hydrochlorothiazide |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 25MG;15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Oct 12, 1984 | TE: | RLD: | Yes | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 25MG;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Oct 12, 1984 | TE: | RLD: | Yes | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 50MG;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Oct 12, 1984 | TE: | RLD: | Yes | |||||
Expired US Patents for NDA 018709
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Apothecon | CAPOZIDE 50/15 | captopril; hydrochlorothiazide | TABLET;ORAL | 018709-004 | Oct 12, 1984 | 4,105,776 | ⤷ Subscribe |
| Apothecon | CAPOZIDE 25/15 | captopril; hydrochlorothiazide | TABLET;ORAL | 018709-001 | Oct 12, 1984 | 4,105,776 | ⤷ Subscribe |
| Apothecon | CAPOZIDE 50/25 | captopril; hydrochlorothiazide | TABLET;ORAL | 018709-003 | Oct 12, 1984 | 4,105,776 | ⤷ Subscribe |
| Apothecon | CAPOZIDE 50/15 | captopril; hydrochlorothiazide | TABLET;ORAL | 018709-004 | Oct 12, 1984 | 4,217,347 | ⤷ Subscribe |
| Apothecon | CAPOZIDE 25/25 | captopril; hydrochlorothiazide | TABLET;ORAL | 018709-002 | Oct 12, 1984 | 4,217,347 | ⤷ Subscribe |
| Apothecon | CAPOZIDE 25/25 | captopril; hydrochlorothiazide | TABLET;ORAL | 018709-002 | Oct 12, 1984 | 4,105,776 | ⤷ Subscribe |
| Apothecon | CAPOZIDE 25/15 | captopril; hydrochlorothiazide | TABLET;ORAL | 018709-001 | Oct 12, 1984 | 4,217,347 | ⤷ Subscribe |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription
